CDK1 and melanoma: A series of paracyclophanyl–thiazole hybrids incorporating a naphthoquinone scaffold was designed and synthesized as potential cyclin-dependent kinase 1 (CDK1) inhibitors, exhibiting pronounced antiproliferative activity against melanoma cells.